Theurillat Group

Theurillat Group

We aim to explore the role of SPOP and CHD1 mutations to develop new therapeutic avenues for prostate cancer.

Alimonti group

Alimonti group

Our research is focused on the characterization of a novel type of cellular senescence response for cancer therapy

Catapano group

Catapano group

We investigate strategies aimed at blocking selectively transcription of genes that might be implicated in pathogenesis of cancer

Bertoni group

Bertoni group

We apply genomics techniques followed by functional studies to elucidate the lesions underlying non-Hodgkin’s lymphomas

Fighting cancer through research. You can support us by making a donation, however large or small.

Support us

About

The Institute of Oncology Research (IOR) hosts a growing number of researchers performing basic and translational research in oncology with special focus in cancer biology, genomics, molecular oncology and experimental therapeutics. The Institute, directed by Carlo Catapano MD, PhD, was established in 2003, formerly as the Laboratory of Experimental Oncology and as part of the Research Division of the Oncology Institute of Southern Switzerland. In September 2011 the IOR became independent and managed administratively through the Lymphoma Foundation (President, Prof. Franco Cavalli). As of January...

Read More

Director’s foreword

Mission statement

Cancer Research